Condition: Urinary Incontinence · Urinary Incontinence,Stress · Sponsor: Uromedica
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
This description comes directly from the study's public registry record.
Lisa Draper · 612-834-7494 · USLDR@COLOPLAST.COM
Matt Kelly, PhD · 612-469-8882 · usmtk@coloplast.com
Always discuss trial participation with your own doctor first.
| University of Colorado | Denver, Colorado, United States | Recruiting |
| CHI Health Research Center | Omaha, Nebraska, United States | Recruiting |
| Hôpital de la Conception - Marseille | Marseille, France | Recruiting |
| CHU de Nantes | Nantes, France | Recruiting |
| Pitié Salpêtrière University Hospital Paris | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04248283